Regulation of Gene Expression By GTF2H2: Potential Drug Target Or Biomarker

Target Name: GTF2H2

NCBI ID: G2966

GTF2H2

Regulation of Gene Expression By GTF2H2: Potential Drug Target Or Biomarker

General transcription factor IIH (GTF2H) is a key regulator of gene expression in the cell. It plays a crucial role in the regulation of stem cell proliferation and differentiation, as well as in the regulation of cell cycle progression. The GTF2H subunit 2, transcript variant 1 is a non-coding RNA molecule that is derived from the GTF2H gene. It has been shown to play a critical role in the regulation of gene expression in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. As a result, GTF2H2 has potential as a drug target or biomarker in a variety of diseases.

The GTF2H gene is located on chromosome 6p11.2 and encodes the GTF2H protein, which is a key regulator of gene expression in the cell. The GTF2H protein is composed of two subunits, GTF2H1 and GTF2H2, which are involved in the regulation of gene expression by binding to specific DNA sequences. GTF2H1 is the major subunit and is responsible for the regulation of gene expression, while GTF2H2 is the smaller subunit that is responsible for the regulation of gene expression by binding to specific DNA sequences.

The GTF2H2 subunit is derived from the GTF2H gene and is expressed in various tissues and cells. It has been shown to play a critical role in the regulation of gene expression in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. For example, studies have shown that GTF2H2 can regulate the expression of genes involved in cell growth and apoptosis, as well as the regulation of cell cycle progression.

In addition to its role in regulating gene expression, GTF2H2 has also been shown to play a critical role in the regulation of cellular processes such as cell adhesion, migration and invasion. GTF2H2 has been shown to play a critical role in the regulation of cell adhesion by binding to the adhesion molecule E-cadherin. This interaction between GTF2H2 and E-cadherin has been shown to play a critical role in the regulation of cell adhesion and the development of cancer.

GTF2H2 has also been shown to play a critical role in the regulation of cell migration and invasion. This is because GTF2H2 is involved in the regulation of the cytoskeleton and the actin cytoskeleton, which are responsible for the movement of cells during the cell cycle. As a result, GTF2H2 has been shown to play a critical role in the regulation of cell migration and invasion, which are important processes in the development of cancer.

In addition to its role in regulating gene expression and cellular processes, GTF2H2 has also been shown to play a critical role in the regulation of stem cell proliferation and differentiation. This is because GTF2H2 is involved in the regulation of stem cell proliferation by binding to the transcription factor p53. This interaction between GTF2H2 and p53 has been shown to play a critical role in the regulation of stem cell proliferation and differentiation.

As a result of its involvement in the regulation of gene expression, cellular processes and stem cell proliferation, GTF2H2 has potential as a drug target or biomarker in a variety of diseases. For example, GTF2H2 has been shown to be involved in the regulation of cancer cell proliferation, and as a result, GTF2H2 has potential as a drug target for cancer. Additionally, GTF2H2 has also been shown to be involved in the regulation of stem cell proliferation, which makes it a potential biomarker for diseases such as cancer, neurodegenerative diseases, and genetic disorders.

In conclusion, GTF2H2 is a non-coding RNA molecule that is derived from the GTF2H gene and is expressed in various tissues and cells. It has been shown to play a critical role in the regulation of gene expression in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. GTF2H2 has potential as a drug target or biomarker in a variety of diseases, including cancer, neurodegenerative diseases, and genetic disorders. Further research is needed to fully understand the role of GTF2H2 in the regulation of gene expression and its potential as a drug target or biomarker.

Protein Name: General Transcription Factor IIH Subunit 2

Functions: Component of the general transcription and DNA repair factor IIH (TFIIH) core complex, which is involved in general and transcription-coupled nucleotide excision repair (NER) of damaged DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. In transcription, TFIIH has an essential role in transcription initiation. When the pre-initiation complex (PIC) has been established, TFIIH is required for promoter opening and promoter escape. Phosphorylation of the C-terminal tail (CTD) of the largest subunit of RNA polymerase II by the kinase module CAK controls the initiation of transcription. The N-terminus of GTF2H2 interacts with and regulates XPD whereas an intact C-terminus is required for a successful escape of RNAP II form the promoter

The "GTF2H2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GTF2H2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets